Long-Term Safety and Efficacy Results in Hepatitis C Virus Genotype 1-Infected Patients Receiving Ombitasvir/Paritaprevir/Ritonavir plus Dasabuvir +/- Ribavirin in the Topaz-I and Topaz-Ii Trials

AuthID
P-00Q-GD2
15
Author(s)
Asatryan, A
·
Dieterich, D
·
Carvalho, A
·
Siddique, A
·
Hu, YR
·
Bondin, M
·
Khan, N
·
Cohen, D
·
Felizarta, F
Document Type
Abstract
Year published
2019
Published
in JOURNAL OF HEPATOLOGY, ISSN: 0168-8278
Volume: 70, Pages: E745-E746 (2)
Conference
International Liver Congress / 54Th Annual Meeting of the European-Association-For-The-Study-Of-The-Liver (Easl), Date: APR 10-14, 2019, Location: Vienna, AUSTRIA, Sponsors: European Assoc Study Liver
Indexing
Publication Identifiers
Wos: WOS:000463481703245
Source Identifiers
ISSN: 0168-8278
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.